Earnings Report /

Speed Medical: 2Q21 – Individual profitability supported by expansions, Prime Speed still weak

  • Revenues surge annually on the back of lab expansions and a weak base effect

  • Healthy margins despite annual GPM contraction

  • SPMD’s operations drive significant bottom-line growth, Prime Speed still pressured by border closure

Merna Arafat
Al Ahly Pharos Securities Brokerage
16 August 2021